In addition, AIL suppressed PD-L1 transcription through the AIL-c-Jun-PD-L1 pathway in melanoma cells, consequently blocking PD-L1 secretion, resulting in Treg inhibition and Foxp3 expression reduction, and ultimately enhancing the efficacy of PD-L1 blockade. Here, JUN is linked to melanoma.